Quick Answer: A foreign cosmetic manufacturer may need to register its facility with FDA when it manufactures or processes cosmetic products for distribution in the United States, unless a statutory exemption applies. Registration is not FDA approval and does not replace the brand owner’s product-listing, safety, labeling, or post-market responsibilities. Foreign facilities must also provide a U.S. agent contact in their registration.
What MoCRA means for foreign cosmetic manufacturers
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) added federal requirements for cosmetic facility registration and cosmetic product listing. The rule is market-facing: it concerns facilities that manufacture or process cosmetics intended for U.S. distribution, wherever those facilities are located. A factory outside the United States should therefore assess the product, facility, and commercial roles for each U.S. launch rather than assume that export status removes the requirement.
FDA’s registration guidance explains that the person who owns or operates a covered facility is responsible for facility registration. The responsible person for a cosmetic product is generally the manufacturer, packer, or distributor whose name appears on the product label; that party is responsible for product listing. In an OEM/ODM relationship, those may be different organizations.
| Question | U.S. MoCRA position | Practical implication for an overseas factory |
|---|---|---|
| Where does the rule apply? | To covered facilities that manufacture or process cosmetics for U.S. distribution. | Location outside the U.S. does not itself remove the assessment. |
| Is there a foreign-factory certificate? | FDA registration is a facility submission, not a certificate of product approval. | Do not market registration as FDA endorsement. |
| Is a U.S. contact needed? | A foreign facility registration must include a U.S. agent. | Confirm the agent’s identity and contact details before submission. |
Is FDA facility registration mandatory for every foreign factory?
No single answer fits every site or product. FDA identifies exemptions and small-business provisions in MoCRA, and a product marketed as a drug, device, or combination product may fall under a different framework. The starting question is whether the site is a covered cosmetic product facility that manufactures or processes cosmetics for U.S. distribution. Brands should document the classification and exemption analysis for their own facts.
Registration must not be confused with product clearance. FDA states that it does not issue certificates or other documents to verify cosmetic compliance, and that registration and listing do not mean FDA approval. Color additives are an important separate area because they are subject to FDA approval requirements.
What information does a foreign facility registration require?
FDA’s current registration guidance and Cosmetics Direct materials set out the information a covered facility should be prepared to submit. The details should be confirmed against the live FDA system when filing, because forms and instructions can change.
| Information area | Why it matters | Who should verify it |
|---|---|---|
| Facility identity and address | Identifies the physical manufacturing or processing location. | Factory owner or operator |
| Owner/operator contact details | Connects the registration to the entity responsible for the facility. | Factory owner or operator |
| U.S. agent name and contact information | Required field for a foreign facility registration. | Foreign facility with its U.S. agent |
| Brand names and product categories | Provides FDA the required facility/product context. | Factory and brand team, using current commercial data |
| Facility Establishment Identifier (FEI), where applicable | FDA guidance describes the identifier used in the registration process. | Factory, with FDA instructions checked before filing |
Manufacturer and brand-owner responsibilities are not interchangeable
A clear role map prevents the common error of asking a factory to “handle MoCRA” without deciding who legally supplies, owns, or maintains each record. Commercial contracts can allocate work, but they do not change the regulatory role shown by the facts and the product label.
| Activity | Typical operational lead | Key check before launch |
|---|---|---|
| Facility registration | Owner or operator of the covered manufacturing/processing facility | Confirm coverage, exemptions, and U.S. agent details. |
| Product listing | Responsible person named on the label | Ensure the listed product information matches the marketed product. |
| Safety substantiation records | Responsible person, supported by technical parties | Keep adequate evidence supporting reasonable certainty of safety. |
| Serious adverse event records and reporting | Responsible person | Set up intake, escalation, and record-retention processes. |
| Manufacturing documentation | Manufacturer | Provide accurate batch, quality, formula, and testing records as agreed. |
A practical MoCRA workflow for an overseas OEM/ODM project
- Classify the product and destination. Confirm it is a cosmetic for U.S. purposes and identify any drug or color-additive issues.
- Map the legal and operational roles. Identify the facility owner/operator and the responsible person named on the label.
- Check facility coverage. Review FDA’s current registration guidance and any available exemption.
- Prepare the facility data. Validate the site address, contact details, brand/product-category information, and U.S. agent data.
- Prepare product-side evidence. The responsible person should align listing, labeling, ingredient, safety, and post-market records.
- Retain an auditable file. Keep submission confirmations, role assignments, and the supporting technical records in a controlled location.
What a cosmetic manufacturer can provide
A manufacturer can support a brand’s U.S. compliance work with accurate technical and quality documentation, subject to the product and commercial arrangement. Useful materials often include the INCI ingredient list, certificate of analysis (COA), safety data sheet (SDS) where relevant, stability information, microbiological reports, packaging-compatibility information, manufacturing quality records, and batch documentation. The brand owner or other responsible person should still verify that the final product, label, claims, listing, and safety file meet its own obligations.
Common mistakes to avoid
- Treating facility registration as product approval. It is not.
- Using a mailbox as a substitute for a real U.S. agent. FDA’s guidance describes a U.S. agent as an individual or entity with a U.S. residence or place of business.
- Assuming an overseas factory can make the product listing disappear. The responsible-person role must still be determined from the label and supply chain.
- Submitting stale product or contact information. Build a change-control process around formula, label, brand, and facility changes.
- Relying on informal summaries instead of the live FDA materials. Recheck official instructions at the time of filing.
FAQ
Does a foreign cosmetics factory need an FDA certificate?
FDA does not provide a cosmetic compliance certificate or an FDA product approval certificate. A covered foreign facility may instead have a facility-registration obligation under MoCRA.
Who is the U.S. agent for a foreign cosmetic facility?
It is the individual or entity identified in the foreign facility’s registration that has a U.S. residence or place of business and can serve as the FDA contact described in the guidance.
Does facility registration replace product listing?
No. Facility registration and cosmetic product listing are distinct MoCRA requirements with different responsible parties and information.
Can an OEM factory submit on behalf of a brand?
Operational help may be arranged, but the party with the applicable legal role must ensure the submission and supporting records are accurate. Confirm roles before filing.
Does FDA registration mean a cosmetic can be sold in the United States?
No. Registration does not establish FDA approval and does not remove requirements concerning safety, labeling, claims, post-market duties, or other applicable laws.
Official sources
- FDA: Registration and Listing of Cosmetic Product Facilities and Products — Guidance for Industry
- FDA: Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
- FDA: clarification on cosmetic compliance certificates and registration/listing
Last reviewed: September 17, 2026. Editorial review: MOOYAM Global Cosmetic Compliance Team.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or qualified compliance professional before placing cosmetic products on the market.
MOOYAM provides cosmetic OEM/ODM manufacturing and technical documentation support for international beauty brands. Contact us to discuss the documentation your launch team may need.